HCA Healthcare (NYSE:HCA – Free Report) had its target price reduced by Truist Financial from $535.00 to $495.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have a buy rating on the stock.
Several other brokerages also recently issued reports on HCA. Stephens decreased their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company set a $369.00 price target on HCA Healthcare in a report on Monday, July 20th. Jefferies Financial Group set a $450.00 price objective on HCA Healthcare in a research report on Tuesday, July 14th. TD Cowen decreased their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Finally, Argus cut their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $465.05.
Check Out Our Latest Analysis on HCA Healthcare
HCA Healthcare Stock Down 2.3%
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.84 earnings per share. As a group, research analysts anticipate that HCA Healthcare will post 29.38 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.45%.
Hedge Funds Weigh In On HCA Healthcare
Several institutional investors and hedge funds have recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. increased its holdings in shares of HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Advisors Capital Management LLC grew its position in HCA Healthcare by 61.5% during the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after purchasing an additional 2,604 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in shares of HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the last quarter. Liberty Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at $1,905,000. Finally, Intech Investment Management LLC raised its stake in HCA Healthcare by 10.0% in the 4th quarter. Intech Investment Management LLC now owns 55,273 shares of the company’s stock worth $25,805,000 after acquiring an additional 5,019 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
Key Stories Impacting HCA Healthcare
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA’s stock outperformed peers during a broadly strong trading session, suggesting some investor support despite recent concerns. HCA stock outperforms competitors
- Positive Sentiment: RBC reiterated its “Outperform” rating, while Mizuho maintained an “Outperform” view and set a $475 price target, implying substantial upside from the recent trading level. RBC reiterates Outperform Mizuho price target
- Positive Sentiment: HCA appointed experienced executives to lead two Tampa hospitals, including a former Oak Hill Hospital executive, and named Jordan Fulkerson chief financial officer of HCA Florida Memorial Hospital. The moves may support local operating continuity. Tampa hospital leadership appointments Memorial Hospital CFO appointment
- Neutral Sentiment: KeyCorp, Truist, and Baird lowered or tempered their HCA price expectations, although the changes reflect analyst caution rather than a broad withdrawal of coverage. KeyCorp set a $435 target, while RBC remained positive. KeyCorp lowers price target Baird forecast Truist price outlook
- Negative Sentiment: A judge rejected a key HCA argument concerning its obligations to provide services at Mission Hospital. Separately, Dogwood Health Trust reported potential noncompliance with the contract governing HCA’s Mission Health acquisition. These developments raise the risk of additional costs, enforcement actions, or operating restrictions. Mission Hospital court ruling Mission contract compliance concerns
- Negative Sentiment: Pomerantz announced an investigation into potential investor claims involving HCA, adding legal overhang and possible reputational risk, although the announcement does not establish wrongdoing. Pomerantz investor investigation
About HCA Healthcare
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
